| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 10/31/2006 | US7129245 Anticoagulants which act selectively on factor Xa; fast acting; oral; do not interfere with lysis of blood clots |
| 10/31/2006 | US7129242 Such as 4-((4-chlorophenyl)pyrimidin-2-yl)amino)benzamide; for treatment of inflammation/autoimmune conditions |
| 10/31/2006 | US7129236 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
| 10/31/2006 | US7129235 Amides useful for treating pain |
| 10/31/2006 | US7129225 Administering an effective amount of a protein tyrosine kinase inhibitor (containing first and second module) to the patient to protect against or to treat hearing loss |
| 10/31/2006 | US7129071 Recombinant methods and materials for producing epothilone and epothilone derivatives |
| 10/31/2006 | US7128896 using carbocyanine dyes; photodynamic therapy; in vivo supplying to tumor |
| 10/31/2006 | CA2355886C Substituted oximes and hydrazones as neurokinin antagonists |
| 10/31/2006 | CA2276455C Phthalazinones |
| 10/31/2006 | CA2256545C Probe for analysis of nucleic acids |
| 10/31/2006 | CA2247419C Oxazole derivatives, their production and use |
| 10/31/2006 | CA2246126C New piperazine compounds |
| 10/31/2006 | CA2230672C Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 10/31/2006 | CA2191759C Formylaminophenylsulfonylureas, preparation processes and use as herbicides and plant growth regulators |
| 10/26/2006 | WO2006113769A1 Vanilloid receptor ligands and their use in treatments |
| 10/26/2006 | WO2006113704A2 Subtituted heteroaryl cb1 antagonists |
| 10/26/2006 | WO2006113458A1 Heterocyclic inhibitors of protein arginine methyl transferases |
| 10/26/2006 | WO2006112549A1 Fused heterocyclic compound |
| 10/26/2006 | WO2006111856A1 Pyrazole derivatives as progesterone receptor antagonists |
| 10/26/2006 | WO2006111516A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex |
| 10/26/2006 | WO2006111491A1 Process for the preparation of 9,10-dehydro-12,13-desoxyepothilone derivatives |
| 10/26/2006 | WO2006094237A3 Acridine and quinoline dervatives as sirtuin modulators |
| 10/26/2006 | WO2006083271A3 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 10/26/2006 | WO2006078621B1 2-phenoxy-n- (1, 3 , 4-thiadizol-2-yl) pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders |
| 10/26/2006 | WO2005113534A3 Cxcr1 and cxcr2 chemokine antagonists |
| 10/26/2006 | WO2005105778A3 4-amino-5-cyanopyrimidine derivatives |
| 10/26/2006 | WO2005099353A3 A novel process for the preparation of linezolid and related compounds |
| 10/26/2006 | WO2005095384A8 Pyrazine derivatives and pharmaceutical use thereof as adenosine antagonists |
| 10/26/2006 | WO2005090311A8 Novel heterocyclyl-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors |
| 10/26/2006 | US20060241297 Pyridinylamino-pyrimidine derivatives as protein kinase inhibitors |
| 10/26/2006 | US20060241156 Preparation of epothilone derivatives |
| 10/26/2006 | US20060241155 TNF-alpha production inhibitors |
| 10/26/2006 | US20060241151 Pyrid-2-one derivatives and methods of use |
| 10/26/2006 | US20060241146 2-cyano-1-[t-4-(4-acetyl-1-piperazinyl)-1-methyl-r-1-cyclohexylamino]acetylpyrrolidine; dipeptidylpeptidase IV (DPPIV) inhibitor; antidiabetic, insulin resistance, hyperglycemia, obesity; antiproliferative agent for T-cell, HIV, AIDS; arthritis, osteoporosis |
| 10/26/2006 | US20060241140 Imidazolamino compounds |
| 10/26/2006 | US20060241138 Heterocyclic amide derivatives for the treatment of diabetes and other diseases |
| 10/26/2006 | US20060241137 Triazole compounds and the therapeutic use thereof |
| 10/26/2006 | US20060241117 Therapeutic agents useful for treating pain |
| 10/26/2006 | US20060241115 2,3-Dihydro-4H-1,4-benzoxazine derivatives containing an optionally fused pyridine or pyrimidine ring; 7-((6,7-bis(methyloxy)-4-quinolinyl)oxy)-N-phenyl-2,3-dihydro-4H-1,4-benzoxazine-4-carboxamide; kinase inhibitors; inflammation, angiogenesis and cancer |
| 10/26/2006 | US20060241111 inhibitors of coagulation factor Xa such as 1-(5-chlorothien-2-ylcarbonyl)-4-[4-(3-oxomorpholin-4-yl)phenyl]-2-propylsemicarbazide, used for preventing thrombosis, infarction, arteriosclerosis, inflammation, bleeding, angina pectoris, restenosis, intermittent claudication and treatment of tumors |
| 10/26/2006 | US20060241110 2-(Imidazol-1-ylalkyl)-3H-quinazolin-4-one derivatives; mitotic kinesin KSP inhibitors; anticarcinogenic, antiinflammatory, and antiproliferative agents |
| 10/26/2006 | US20060241109 PGD2 receptor antagonists for the treatment of inflammatory diseases |
| 10/26/2006 | US20060241106 Isoxazole compounds as inhibitors of heat shock proteins |
| 10/26/2006 | US20060241105 To control arthropods (including insects and arachnids) and helminths (including nematodes) also valuable to protect timber from sawflies, beetles or termites or use in veterinary medicine; 1-(2,6-Dichloro-4-trifluoromethylphenyl)-3-(N-benzyloxy-2-amidino)-5-methylamino-4-trifluoromethylsulfonylpyrazole |
| 10/26/2006 | US20060241096 Agent for preventing or treating organ functional disorders and organ dysfunction |
| 10/26/2006 | DE102005020104A1 New thiazolidinone compounds are polo-like kinase inhibitors, useful for the preparation of medicament to treat e.g. cancer, autoimmune disease, cardiovascular disease stenosis and infection disease |
| 10/26/2006 | DE102005018389A1 Azolderivate als Inhibitoren von Lipasen und Phospholipasen Azole derivatives as inhibitors of lipases and phospholipases |
| 10/26/2006 | CA2606288A1 Subtituted heteroaryl cb1 antagonists |
| 10/26/2006 | CA2605778A1 Fused heterocyclic compound |
| 10/26/2006 | CA2604942A1 2-amino-quinaz0lin-5-ones |
| 10/26/2006 | CA2604920A1 Novel compounds useful for bradykinin b1 receptor antagonism |
| 10/26/2006 | CA2604257A1 Process for the preparation of 9,10-dehydro-12,13-desoxyepothilone derivatives |
| 10/26/2006 | CA2604218A1 Pyrazole derivatives as progesterone receptor antagonists |
| 10/25/2006 | EP1714652A2 Use of thiazolidinediones to prevent or delay onset of niddm |
| 10/25/2006 | EP1713823A2 Hcv ns-3 serine protease inhibitors |
| 10/25/2006 | EP1713822A2 Hcv ns-3 serine protease inhibitors |
| 10/25/2006 | EP1713807A1 Vanilloid receptor ligands and their use in treatments |
| 10/25/2006 | EP1713799A2 Compounds and compositions as lxr modulators |
| 10/25/2006 | EP1713780A2 Novel inhibitors of glutaminyl cyclase |
| 10/25/2006 | EP1713778A1 Benzazepine derivatives as histamine h3 antagonists |
| 10/25/2006 | EP1713774A1 New pyridin-2-one compounds useful as inhibitors of thrombin |
| 10/25/2006 | EP1713772A1 Novel piperidines as chemokine modulators (ccr) |
| 10/25/2006 | EP1713484A2 Compounds and methods of use |
| 10/25/2006 | EP1590346B1 4- {'3-(sulfonylamino) phenyl] '1-(cyclymethyl) piperidin-4-ylidene] methyl} benazmide derivatives as delta opioid receptor ligands for the treatment of pain, anxiety and functional gastrointestinal disorder |
| 10/25/2006 | EP1567501B1 Propanamine derivatives as serotonin and norepinephrine reuptake inhibitors |
| 10/25/2006 | EP1554272B1 Benzimidazoles and benzothiazoles as inhibitors of map kinase |
| 10/25/2006 | EP1409525B1 Human papillomavirus e2 transactivation domain/inhibitor co-crystal and x-ray coordinates defining the inhibitor-binding pocket |
| 10/25/2006 | EP1370543B1 Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors |
| 10/25/2006 | EP1315721B1 A thiazolidinedione derivative and its use as antidiabetic |
| 10/25/2006 | EP1265606B1 Cell adhesion inhibitors |
| 10/25/2006 | EP1235805B1 Immunoassay for neonicotinyl insecticides |
| 10/25/2006 | EP1089998B1 Epothilone derivatives and their synthesis and use |
| 10/25/2006 | CN1852907A 2-amino-5-benzoylthiazole npy antagonists |
| 10/25/2006 | CN1852905A N-substituted benzimidazolyl c-kit inhibitors |
| 10/25/2006 | CN1852896A Quinoline and quinazoline derivatives having affinity for 5HT1-type receptors |
| 10/25/2006 | CN1852714A Quinazoline analogs as receptor tyrosine kinase inhibitors |
| 10/25/2006 | CN1852712A Dual NK1/NK3 antagonists for treating schizophrenia |
| 10/25/2006 | CN1852710A Pyrazolines as PAR-1 antagonists for treatment of cardiovascular diseases |
| 10/25/2006 | CN1850822A Method for preparing pioglitazone |
| 10/25/2006 | CN1281605C Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 10/25/2006 | CN1281592C Process for preparing 1,2,4-benzothiadiaxine-1,1-dioxide compound |
| 10/25/2006 | CN1281585C Cyclic diamine compounds having fused-ring groups |
| 10/24/2006 | US7126010 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 10/24/2006 | US7125997 Differential tumor cytotoxicity compounds and compositions |
| 10/24/2006 | US7125994 PNA monomer and precursor |
| 10/24/2006 | US7125989 Hetero diels-alder adducts of pentacene as soluble precursors of pentacene |
| 10/24/2006 | US7125988 Forms an azomethine dye upon a coupling reaction with an oxidized product of a developing agent; excellent in color reproducibility and image storability |
| 10/24/2006 | US7125901 Thiazole derivatives |
| 10/24/2006 | US7125900 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 |
| 10/24/2006 | US7125899 Microtubule-stabilizing agents useful in the treatment of a variety of cancers |
| 10/24/2006 | US7125898 Kinase inhibitors to mediate disease and as antiinflammatory agents |
| 10/24/2006 | US7125896 Thiophene carboxamide compounds as inhibitors of enzyme IKK-2 |
| 10/24/2006 | US7125893 Compounds useful for treatment of tumors or cancer of the stomach, colon, neck or used in angiogenesis and forming the compound with cyclization |
| 10/24/2006 | US7125891 Such as (1-((2,3-dihydro-2-(4-propyl-1H-imidazol-2-yl)-1H-indol-1 -yl)carbonyl)propyl)-carbamate; for inactivation of cholecystokinins |
| 10/24/2006 | US7125883 alpha v beta 3 integrin receptor modulators; treating variety of diseases including cardiovascular disorders, retinopathy, strokes, cancer, osteoporosis, tumor metastasis, high blood pressure, psoriasis, antiviral, antimycotic, antiparasitic or antibacterial therapy; 1,2-dihydropyrimidin-2-one moiety |
| 10/24/2006 | US7125879 Prevention reproduction of virus |
| 10/24/2006 | US7125876 Substituted heterocyclic compounds |
| 10/24/2006 | US7125875 Cyclic protein tyrosine kinase inhibitors |
| 10/24/2006 | US7125870 such as N-hydroxy-2-{3-[4-(2-methyl-quinolin-4-ylmethoxy)-phenyl]-4,5-dihydro-isoxazol-5-yl}-acetamide; kits; for treatment of inflammation |
| 10/24/2006 | US7125865 and atherosclerosis; LXR agonists which increase HDL levels; increases ABCA1 gene expression; reverse cholesterol transport; 1,2-benzisoxazole 6-yl compounds |